...
首页> 外文期刊>Eukaryotic cell >Eukaryotic UDP-Galactopyranose Mutase (GLF Gene) in Microbial and Metazoal Pathogens
【24h】

Eukaryotic UDP-Galactopyranose Mutase (GLF Gene) in Microbial and Metazoal Pathogens

机译:微生物和后生菌病原体中的真核UDP-半乳糖苷酶(GLF基因)

获取原文
           

摘要

Galactofuranose (Galf) is a novel sugar absent in mammals but present in a variety of pathogenic microbes, often within glycoconjugates that play critical roles in cell surface formation and the infectious cycle. In prokaryotes, Galf is synthesized as the nucleotide sugar UDP-Galf by UDP-galactopyranose mutase (UGM) (gene GLF). Here we used a combinatorial bioinformatics screen to identify a family of candidate eukaryotic GLFs that had previously escaped detection. GLFs from three pathogens, two protozoa (Leishmania major and Trypanosoma cruzi) and one fungus (Cryptococcus neoformans), had UGM activity when expressed in Escherichia coli and assayed in vivo and/or in vitro. Eukaryotic GLFs are closely related to each other but distantly related to prokaryotic GLFs, showing limited conservation of core residues around the substrate-binding site and flavin adenine dinucleotide binding domain. Several eukaryotes not previously investigated for Galf synthesis also showed strong GLF homologs with conservation of key residues. These included other fungi, the alga Chlamydomonas and the algal phleovirus Feldmannia irregularis, parasitic nematodes (Brugia, Onchocerca, and Strongyloides) and Caenorhabditis elegans, and the urochordates Halocynthia and Cionia. The C. elegans open reading frame was shown to encode UGM activity. The GLF phylogenetic distribution suggests that Galf synthesis may occur more broadly in eukaryotes than previously supposed. Overall, GLF/Galf synthesis in eukaryotes appears to occur with a disjunct distribution and often in pathogenic species, similar to what is seen in prokaryotes. Thus, UGM inhibition may provide an attractive drug target in those eukaryotes where Galf plays critical roles in cellular viability and virulence.
机译:半乳糖呋喃糖(Gal f )是哺乳动物中不存在的新型糖,但存在于多种致病微生物中,通常存在于糖缀合物中,这些糖缀合物在细胞表面形成和感染周期中起关键作用。在原核生物中,Gal f 是通过UDP-半乳糖吡喃糖(UGM)合成为核苷酸糖UDP-Gal f )(基因 GLF )。在这里,我们使用了组合生物信息学屏幕来识别先前逃避检测的候选真核生物 GLF 家族。来自三种病原体的 GLF ,两种原生动物(大利什曼原虫克鲁斯锥虫)和一种真菌(新隐球菌)在大肠杆菌中表达并在体内和/或体外测定时,具有UGM活性。真核 GLF 彼此密切相关,但与原核 GLF 密切相关,显示底物结合位点和黄素腺嘌呤二核苷酸结合结构域周围核心残基的保守性有限。以前未对Gal f 合成进行过研究的几种真核生物也显示出很强的 GLF 同源物,并保留了关键残基。其中包括其他真菌,藻类的衣原体和藻状细小病毒不育的费德曼菌,寄生线虫( Brugia Onchocerca 类硬质体)和秀丽隐杆线虫,以及泌尿生殖器的 Halocynthia Cionia C。线虫开放阅读框显示出编码UGM活性。 GLF 的系统发育分布表明,Gal f 的合成可能在真核生物中比以前想象的更广泛。总体而言,真核生物中的 GLF / Gal f 合成似乎是不连续的分布,并且通常在致病性物种中发生,与原核生物类似。 。因此,在Gal f 在细胞生存力和毒力中起关键作用的真核生物中,UGM的抑制作用可能提供了有吸引力的药物靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号